SCHEMBL10323322

SCHEMBL10323322

COc1cc(C(=O)Cl)cc(Cl)c1OCc1ccccc1

nearest known ligand 0.79

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.62
GLRA1 P23415 1/20 0.59
SMN1; SMN2 Q16637 2/20 0.54
ALDH1A1 P00352 2/20 0.54
MEN1 O00255 2/20 0.54
KMT2A Q03164 2/20 0.54
MAPK1 P28482 1/20 0.54
NPSR1 Q6W5P4 1/20 0.54
ADCYAP1R1 P41586 1/20 0.52
HPGD P15428 2/20 0.51
NPC1 O15118 1/20 0.51
RAB9A P51151 1/20 0.51
SMPD1 P17405 1/20 0.50
HDAC1 Q13547 1/20 0.50
HDAC8 Q9BY41 1/20 0.50
HDAC6 Q9UBN7 1/20 0.50
LMNA P02545 1/20 0.49
SLC6A5 Q9Y345 3/20 0.48
MRGPRX4 Q96LA9 2/20 0.48
PTPN2 P17706 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10429197 0.92 GLRA1 (0.64) KDM4EGLRA1SMN1; SMN2MEN1KMT2A
SCHEMBL10323084 0.91 KDM4E (0.64) KDM4ESMN1; SMN2ALDH1A1MEN1KMT2A
SCHEMBL4901522 0.87 GLRA1 (0.65) KDM4EGLRA1SMN1; SMN2ALDH1A1MEN1
SCHEMBL3229895 0.87 KDM4E (0.60) KDM4ESMN1; SMN2ALDH1A1MEN1KMT2A
SCHEMBL29136484 0.87 HPGD (0.63) KDM4EGLRA1SMN1; SMN2MEN1KMT2A
SCHEMBL3227053 0.86 KDM4E (0.62) KDM4ESMN1; SMN2ALDH1A1MEN1KMT2A
SCHEMBL31192445 0.86 KDM4E (0.59) KDM4ESMN1; SMN2ALDH1A1MEN1KMT2A
SCHEMBL31192441 0.85 KDM4E (0.64) KDM4ESMN1; SMN2ALDH1A1MEN1KMT2A
SCHEMBL11345190 0.83 GLRA1 (0.60) KDM4EGLRA1SMN1; SMN2MEN1KMT2A
SCHEMBL10324062 0.83 GLRA1 (0.54) KDM4EGLRA1SMN1; SMN2MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2484669-B1 PHENOL DERIVATIVES FUJI YAKUHIN CO LTD (JP) 2015-07-29 EP disclosed
CN-102639518-B Novel Phenol Derivatives FUJI YAKUHIN CO LTD 2015-03-25 CN disclosed
US-8367843-B2 Phenol derivative FUJI YAKUHIN CO., LTD. (JP) 2013-02-05 US disclosed
CN-102639518-A Novel Phenol Derivatives FUJI YAKUHIN CO LTD 2012-08-15 CN disclosed
EP-2484669-A1 NOVEL PHENOL DERIVATIVE Fuji Yakuhin Co., Ltd. (JP) 2012-08-08 EP disclosed
US-20120184587-A1 NOVEL PHENOL DERIVATIVE FUJI YAKUHIN CO., LTD. (JP) 2012-07-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120184587-A1 NOVEL PHENOL DERIVATIVE XDH, REN, UTS2R KDM4E 2141/4885GLRA1 2739/4885SMN1; SMN2 3904/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.